135.57 USD
-5.05 (-3.59%)
135.57 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to NBIX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 181.85. This target is 34.13% above the current price.
NBIX was analyzed by 35 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-08 | Truist Securities | Maintains | Buy -> Buy |
| 2026-01-08 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-12-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-12-12 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-12-11 | Stifel | Maintains | Buy -> Buy |
| 2025-12-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-05 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-03 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-30 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-10-29 | Needham | Maintains | Buy -> Buy |
| 2025-10-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-29 | Stifel | Maintains | Buy -> Buy |
| 2025-10-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-29 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-21 | Citigroup | Initiate | Buy |
| 2025-10-20 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-09 | UBS | Maintains | Buy -> Buy |
| 2025-09-22 | Needham | Maintains | Buy -> Buy |
| 2025-09-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-01 | Guggenheim | Maintains | Buy -> Buy |
| 2025-07-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-31 | Stifel | Maintains | Buy -> Buy |
| 2025-07-31 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-07-31 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-07-31 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-22 | Morgan Stanley | Maintains | Overweight -> Overweight |
NEUROCRINE BIOSCIENCES INC / NBIX FAQ
Can you provide the average price target for NEUROCRINE BIOSCIENCES INC stock?
35 analysts have analysed NBIX and the average price target is 181.85 USD. This implies a price increase of 34.13% is expected in the next year compared to the current price of 135.57.
Can you provide the consensus rating for NEUROCRINE BIOSCIENCES INC stock?
The consensus rating for NEUROCRINE BIOSCIENCES INC (NBIX) is 84.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover NEUROCRINE BIOSCIENCES INC (NBIX) stock?
The number of analysts covering NEUROCRINE BIOSCIENCES INC (NBIX) is 35.